NCT07098663: Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
- State
- Under way
- Phase
- Phase 2
- People
- 68 planned
- Started
- 12 Aug 2025
- Primary completion
- 19 Jan 2026
- Arms
- Part 1- MKP10241 400 mg, Part 2 - MKP10241 200 mg, 300 mg and 400 mg, Part 3 - MKP10241 300 mg and 400 mg
- Results
- None posted
- 1 Aug 2025: Trial registered
- 12 Aug 2025: Trial started